Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Status unconfirmed · Phase 1

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy combined with temozolomide in treating patients who have metastatic melanoma.

Key facts

Study ID
NCT00016055
Run by
St. Luke's Medical Center
People needed
18
Starts
2000-11-01
Last updated by the study team
2013-09-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.